Introduction
============

Chiral 2-oxazolidinones, widely used as Evans\' chiral auxiliaries ([Scheme 1a](#sch1){ref-type="fig"}, left), play a prominent role in modern organic synthesis.[@cit1] Based on chiral 2-oxazolidinone auxiliaries, a wide range of asymmetric transformations has been developed to construct new chiral building blocks, which are frequently used in both natural product synthesis and drug discovery.[@cit2] Furthermore, the chiral 2-oxazolidinone motif itself is common in pharmaceutically relevant molecules ([Scheme 1a](#sch1){ref-type="fig"}, right).[@cit3] Thus, the synthesis of chiral 2-oxazolidinones has already attracted considerable attention. Conventionally, enantioenriched 2-oxazolidinones are synthesized by cyclization of the corresponding optically pure β-amino alcohols with C1-building blocks like phosgene and its derivatives ([Scheme 1b](#sch1){ref-type="fig"}). These methods often require toxic reagents and the pre-construction of the key stereocenter of the β-amino alcohols arises synthetic problems if they cannot be formed from natural enantiopure amino acids or related precursors.[@cit2] Considering this, the exploration of orthogonal, efficient and divergent catalytic strategies for the construction of diverse 2-oxazolidinone derivatives is highly important for organic synthesis and drug discovery.

![Applications and synthesis of chiral 2-oxazolidinones.](c8sc01869c-s1){#sch1}

In the last decade, the asymmetric hydrogenation of unsaturated heterocycles has emerged as a conceptually powerful method to produce optically active cyclic compounds and has received significant attention.[@cit4] In this regard, a synthetic method utilizing the enantioselective hydrogenation of 2-oxazolones for the late-stage construction of the key stereocenter can be envisioned as a powerful alternative to prepare diverse optically active 2-oxazolidinones ([Scheme 1c](#sch1){ref-type="fig"}). Moreover, this strategy would also provide a general way to produce optically active β-amino alcohols since the transformation from 2-oxazolidinones to free β-amino alcohols is very convenient.[@cit2] Recently, Zhang and co-workers reported the rhodium-catalysed asymmetric hydrogenation of 2-oxazolones, which afforded 4-aryl substituted 2-oxazolidinones with moderate enantioselectivities.[@cit5] To the best of our knowledge, this is the only precedent of an enantioselective synthesis of chiral 2-oxazolidinones by asymmetric hydrogenation of unsaturated heterocycles. As a continuous effort in the field of arene and heterocycle hydrogenation,[@cit6] we herein describe a highly enantioselective and practical hydrogenation of a broad scope of 2-oxazolones to access diverse enantioenriched 2-oxazolidinones catalysed by a ruthenium([ii]{.smallcaps})--N-heterocyclic carbene (NHC) complex.

Results and discussion
======================

Initially, the hydrogenation of 4-phenyloxazol-2(3*H*)-one (**1a**) was attempted under 50 bar H~2~ in *n*-hexane at room temperature in the presence of our previously-developed ruthenium([ii]{.smallcaps})--NHC catalyst, which is prepared *in situ* from \[Ru(2-methylallyl)~2~(COD)\], the NHC precursor (*R*,*R*)-SINpEt·HBF~4~, and NaO*t*-Bu.[@cit7],[@cit8] However, the desired product was not observed, presumably due to catalyst deactivation by coordination of the metal with free N--H ([Table 1](#tab1){ref-type="table"}, entry 1). To circumvent catalyst deactivation, a variety of protecting groups were investigated, of which the 4-methoxybenzyl (PMB) protected carbamate **1d** was found to be suitable for hydrogenation, providing the desired 4-phenyloxazolidin-2-one with 85% *ee* and in 95% isolated yield (entry 2--4). To further improve the reaction conditions, a solvent screen was conducted (entries 4--8). No reaction occurred in dichloromethane presumably due to catalyst decomposition (entry 5), and cyclohexane (entry 8) was found to be slightly superior to other solvents (*n*-hexane, toluene and THF) for enantioselectivity. Decreasing the reaction temperature to 0 °C further improved enantiocontrol, providing the desired product with 95% *ee* and in 93% yield (entry 9). Finally, a solvent mixture of cyclohexane/THF = 20/1 was used to improve the solubility of the substrate, to afford the chiral 2-oxazolidinone **2d** in 99% yield and 95% *ee* (entry 10).

###### Optimisation of the reaction conditions[^*a*^](#tab1fna){ref-type="fn"}

  ![](c8sc01869c-u1.jpg){#ugr1}                                                         
  ------------------------------------------ -------------- ------------- ---- -------- -------
  1                                          H (**1a**)     *n*-Hexane    25   0        ---
  2                                          Boc (**1b**)   *n*-Hexane    25   Traces   N. D.
  3                                          Ac (**1c**)    *n*-Hexane    25   0        ---
  4                                          PMB (**1d**)   *n*-Hexane    25   95       85
  5                                          PMB (**1d**)   CH~2~Cl~2~    25   0        ---
  6                                          PMB (**1d**)   Toluene       25   99       85
  7                                          PMB (**1d**)   THF           25   99       87
  8                                          PMB (**1d**)   Cyclohexane   25   98       88
  9                                          PMB (**1d**)   Cyclohexane   0    93       95
  10[^*d*^](#tab1fnd){ref-type="table-fn"}   PMB (**1d**)   Cyclohexane   0    99       95

^*a*^General conditions: \[Ru(2-methylallyl)~2~(COD)\] (0.10 mmol), (*R*,*R*)-SINpEt·HBF~4~ (0.20 mmol) and NaO*t*-Bu (0.24 mmol) were stirred at 70 °C in *n*-hexane (5.0 mL) for 16 h to perform the catalyst (0.02 M), after which 0.1 mL of the catalyst suspension were added to substrates **1a--d** (0.10 mmol) in the indicated solvent (1.0 mL), and the hydrogenation was performed at 50 bar H~2~ for 24 h.

^*b*^Yields of isolated product after column chromatography are reported.

^*c*^Determined by HPLC analysis using a chiral stationary phase.

^*d*^Using a solvent mixture of cyclohexane/THF = 20/1. Boc = *tert*-butyloxycarbonyl, Ac = acetyl, PMB = 4-methoxybenzyl. N. D. = not determined.

With the optimised reaction conditions in hand ([Table 1](#tab1){ref-type="table"}, entry 10), the substrate scope of the reaction was explored ([Schemes 2](#sch2){ref-type="fig"} and [3](#sch3){ref-type="fig"}). First, the variation of the protecting group from *N*-PMB to *N*-methyl afforded the products with similar results ([Scheme 2](#sch2){ref-type="fig"}, **2d** and **2e**). Next, the positional influence of substituents on the phenyl ring was investigated. Methyl groups in the 2-, 3- and 4-positions were well-tolerated, providing the corresponding 2-oxazolidinones with excellent enantioselectivities and in high yields (**2f--h**). The electronic effect of the substituents was also examined. Both, electron-rich and electron-deficient substrates (**1i** and **1j** respectively) underwent hydrogenation to smoothly afford products **2i** and **2j**. Halogenated substrates **1k--m** were also used to provide the desired products **2k--m** with excellent enantioselectivities, in very high yields and without the formation of dehalogenated byproducts. Notably, the catalytic system showcased a robust reactivity, tolerating various functional groups and useful motifs (such as SMe, 1,3-benzodioxole, morpholine, CO~2~Me and SO~2~Me) to provide the corresponding products **2o--s** with 91--96% *ee* and in 76--99% yield. These functional groups and motifs (**2i--s**) provide an excellent opportunity for further applications of the 2-oxazolidinone products. In addition, the absolute configuration of **2s** was determined to be (*R*) by X-ray crystallographic analysis.[@cit9] The absolute configuration of all other products was assigned by analogy. Additionally, substrates with condensed-ring and heteroaromatic moieties were also tested. Both 1- and 2-naphthyl-substituted substrates were tolerated under the standard conditions (**2t** and **2u**). Remarkably, thiophene and pyridine containing substrates did not poison the Ru--NHC catalyst, producing the corresponding products (**2v** and **2w**) with 93% *ee* and 94% *ee* respectively.

![Substrate scope of 4-aryl or 4-heteroaryl substituted 2-oxazolones. General conditions: \[Ru(2-methylallyl)~2~(COD)\] (0.10 mmol), (*R*,*R*)-SINpEt·HBF~4~ (0.20 mmol) and NaO*t*-Bu (0.24 mmol) were stirred at 70 °C in *n*-hexane (5.0 mL) for 16 h to perform the catalyst (0.02 M), after which 0.2 mL of the catalyst suspension were added to substrates **1d--s** (0.20 mmol) in cyclohexane/THF (20/1), and the hydrogenation was performed under 50 bar H~2~ at 0 °C for 24 h. Yields of isolated products after column chromatography are reported. % *ee* values were determined by HPLC analysis using a chiral stationary phase. ^*a*^Using a solvent mixture of cyclohexane/THF (1/1). ^*b*^Using THF (2.0 mL). ^*c*^At --10 °C.](c8sc01869c-s2){#sch2}

![Substrate scope of 4-alkyl substituted 2-oxazolones. For detailed conditions, see ESI.[†](#fn1){ref-type="fn"} Yields of isolated products after column chromatography are reported. % *ee* values were determined by HPLC analysis using a chiral stationary phase. ^*a*^Using 5 mol% of the catalyst.](c8sc01869c-s3){#sch3}

We further explored the substrate scope with 4-alkyl substituents ([Scheme 3](#sch3){ref-type="fig"}). Alkyl substituted substrates with different steric demand were systematically tested. Simple 4-methyloxazolidin-2-one **2x** was obtained with moderate enantioselectivity. Better control of the stereoselectivity was observed when introducing *n*-butyl substituent (**2y**). Isopropyl, cyclopropyl, and cyclohexyl substituents were successfully employed, affording the corresponding products with 91--94% *ee* and in 92--95% yield (**2z--ab**). Finally, *tert*-butyl substituted 2-oxazolone **1ac** was tolerated to give the product **2ac** with 90% *ee* and in 83% yield. These results indicate that bulky alkyl groups are beneficial for the enantioinduction. In addition, bicyclic 2-oxazolidinone **2ad** was also obtained by the developed method, albeit with moderate *ee*.

We then proceeded to demonstrate applications of this methodology ([Scheme 4](#sch4){ref-type="fig"}). Scale-up of the hydrogenation of 4-(1-naphthyl) substituted substrate **1t** to gram-scale provided the corresponding 2-oxazolidinone **2t** with 95% *ee* and in 99% yield ([Scheme 4a](#sch4){ref-type="fig"}). Remarkably, the catalyst loading was successfully reduced to 0.2 mol%, which greatly increases the synthetic viability of this protocol. The deprotection of the PMB group was conveniently completed to afford **3** in 99% yield and without loss of enantiomeric excess.[@cit6d] Hydrolysis of **2t** using NaOH liberated the *N*-PMB β-amino alcohol **4** in 92% yield. The enantiopurity of product **3** was readily increased to \>99% *ee* after recrystallization from ethyl acetate. Optically pure β-amino alcohol **5** was then prepared in quantitative yield by cleavage of the 2-oxazolidinone **3** using diethylenetriamine ([Scheme 4b](#sch4){ref-type="fig"}).[@cit10] The absolute configuration of β-amino alcohol **5** was reaffirmed to be (*R*) by comparing the optical rotation to the literature data.[@cit11] The β-amino alcohol **5** was further transformed into 1-naphthyl-substituted bisoxazoline ligand **6** in 74% yield by reaction with dimethylmalononitrile and Zn(OTf)~2~.[@cit11a],[@cit12] Furthermore, aryl iodide and different *N*-alkyl substituted substrate **1ae** was well tolerated under the established reaction conditions ([Scheme 4c](#sch4){ref-type="fig"}). Hydrogenation of **1ae** using (*S*,*S*)-SINpEt·HBF~4~ as the carbene ligand precursor, furnished the oxazolidinone **2ae** (92% *ee* and 96% yield), a key synthetic intermediate employed in the synthesis of the alkaloid (--)-aurantioclavine.[@cit13]

![Scaled-up hydrogenation and transformations of the products.](c8sc01869c-s4){#sch4}

Conclusions
===========

In summary, we have developed a protocol for the catalytic enantioselective hydrogenation of 2-oxazolones to obtain optically active 2-oxazolidinone derivatives. The ruthenium([ii]{.smallcaps})--NHC catalyst system enabled a broad range of substrates to be successfully hydrogenated with excellent enantioselectivities (up to 96% *ee*) and in yields (up to 99%), thus to make the approach practical for the first time. Various functional groups and synthetically useful motifs were well-tolerated. The synthetic utility of this protocol was further demonstrated by performing a reaction on a gram-scale with a reduced catalyst loading; the obtained enantioenriched product was readily converted into an optically pure β-amino alcohol and subsequently a bisoxazoline ligand. The formal synthesis of (--)-aurantioclavine was enabled by the functional group tolerance towards an iodine substituent at the aryl ring and a varied *N*-alkyl chain.
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